Technology
Health
Pharmaceutical

Aridis Pharmaceuticals

$10.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.23 (-2.13%) Today
+$0.35 (3.33%) After Hours

Why Robinhood?

You can buy or sell ARDS and other stocks, options, ETFs, and crypto commission-free!

About

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-105, AR-101, AR-401, AR-201, and AR-501. Read More The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in San Jose, CA.

Employees
Headquarters
San Jose, California
Founded
2003
Market Cap
Price-Earnings Ratio
Dividend Yield
Average Volume
11.77K
High Today
$11.32
Low Today
$10.40
Open Price
$11.00
Volume
598.00
52 Week High
$13.85
52 Week Low
$7.59

Collections

Technology
Health
Pharmaceutical
2018 IPO
US
North America

Earnings

-$1.97
-$1.83
-$1.69
-$1.55
Q3 2018
Q4 2018
Estimated
-$1.55 per share
Actual
Expected Today, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.